Stridor | NYU Langone Health
Otolaryngologists at NYU Langone’s Voice Center specialize in diagnosing and treating stridor.
Stridor in Children | NYU Langone Health
Specialists at Hassenfeld Children’s Hospital at NYU Langone use a physical exam, imaging tests, and laryngoscopy to diagnose stridor in children.
STRIKE-PE: A Prospective Multicenter Study of the IndigoTM Aspiration System Seeking to Evaluate the Long-Term Safety and Outcomes of Treating Pulmonary Embolism
This is a post-market, observational, prospective, multicenter study to evaluate real world long-term functional outcomes, safety and performance of the Indigo Aspiration System for the treatment of pulmonary embolism (PE).
Stroke | NYU Langone Health
The specialists at NYU Langone’s Comprehensive Stroke Care Center diagnose stroke and provide rapid, effective treatment.
Stroke Center at NYU Langone Hospital—Suffolk | NYU Langone Health
Experts at the Stroke Center at NYU Langone Hospital—Suffolk offer rapid diagnosis, treatment, and rehabilitation.
Stroke Center at NYU Langone Hospital—Suffolk Doctors | NYU Langone Health
Find a doctor at Stroke Center at NYU Langone Hospital—Suffolk.
Stroke Treatment Outcomes at NYU Langone | NYU Langone Health
Read more about NYU Langone’s stroke treatment results, including standard and advanced treatment outcomes.
Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)
IBD Plexus is a research and information exchange platform whose goal is to accelerate research and transform the care of patients with IBD. IBD Plexus will unite clinicians, patients, academic and industry researchers to answer questions that are critically important to advance the field of IBD research and to accelerate progress toward precision medicine.IBD Plexus connects and centralizes clinical, patient-reported, biosamples and derived ‘omic/ expression data across multiple patient cohorts. IBD Plexus consists of a biobank, registries to capture clinical, patient-reported, and biosample data, a centralized analytics lab to conduct omics and expression analysis, a large data management platform to house, organize, aggregate and disseminate data, and a researcher portal which provides access to prep-to-research tools and high performance cloud computing.The various components of IBD Plexus provide the infrastructure and capacities to dramatically shift the IBD research paradigm by facilitating novel, potentially groundbreaking studies into IBD’s causes and treatments.These components will include data from the CCFA’s Quality of Care Initiative, the CCFA Partner’s cohort study, the RISK cohort study, and the SPARC IBD study described in this protocol.
Study of inherited monogenic disorders in patient and tissue-specific cells
We propose to collect blood samples to reprogram into patient-specific neuronal, cardiac, and cancer cell lines (see below in the background section) from patients diagnosed with inherited epilepsy & neurodevelopmental disorders (NDDs) and arrhythmias & neuromuscular disorders (NMDs).
Study of newly identified natriuretic protein haptoglobin related protein without signal peptide as biomarker for renal salt wasting and new syndrome of renal salt wasting in Alzheimer s disease: Study to identify protein that alters brain cell function in Alzheimer s disease
This study is being done to better understand hyponatremia (low blood sodium). We have now identified a protein that may be used to diagnose a cause of hyponatremia, cerebral/renal salt wasting (C/RSW). C/RSW is the loss of excessive amounts of salt and water in the urine and is what causes dehydration or too little salt and water in your body. The dehydration can be severe enough to cause low blood pressure, weakness, loss of appetite, dizziness, confusion, trouble walking and even fainting, especially when you stand up. We have also identified that the same protein is present in the blood of subjects with C/RSW and with Alzheimer’s disease (AD). We have also shown that the brain cells of subjects with Alzheimer’s disease are altered. The major aims of this study are to: Develop the protein to help diagnose C/RSW. Use the protein to identify a new syndrome of C/RSW in subjects with Alzheimer’s disease and Identify the protein in the blood of subjects with Alzheimer’s disease that causes their brains cell to alter their function. We can then inhibit the function of this protein to possibly prevent the dementia of Alzheimer disease.